Table 3.

Laboratory Data, Echocardiography Findings, and Composite Congestion Score in Heart Failure Patients (n=86)

Laboratory data
Hemoglobin (g/dL)	12 [11–14]
Platelet (×103/μL)	21 [18–25]
T-Bil (mg/dL)	0.7 [0.5–0.9]
AST (U/L)	22 [19–27]
ALT (U/L)	18 [13–26]
γ-GTP (U/L)	26 [18–53.5]
ALP (U/L)	231 [192–293]
eGFR (mL/min/1.73 m2)	45 [29–67]
Sodium (mEq/L)	140 [138–143]
BNP (pg/mL)	182 [77–421]
Echocardiography
LVEDV (mL)	76 [59–102]
LVSDV (mL)	32.5 [26–56.75]
LVEF (%)	52 [38–62]
LAVI (mL/m2)	40 [30–52]
E/A	0.8 [0.7–1.3]
E/e’	12 [9–16]
LVOT-VTI (cm)	17 [13–22]
TRPG (mmHg)	23 [18.5–28.5]
Maximum IVC diameter (mm)	13 [11–16]
TAPSE (mm)	17 [14–20]
Pulsed Doppler S wave (cm/s)	10 [8.5–12]
RVFAC (%)	36 [28–44]
MR III/IV	5 (6)
TR III/IV	11 (13)
CCS	0 [0–1]

Values are expressed as the median [interquartile range] or n (%). A, late transmitral flow velocity; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BNP, B-type natriuretic peptide; CCS, composite congestion score; E, early transmitral flow velocity; E/e’, ratio of peak mitral E wave velocity to peak early diastolic myocardial velocity at septal and lateral position recorded using tissue Doppler imaging; eGFR, estimated glomerular filtration rate; γ-GTP, γ-glutamyl transpeptidase; IVC, inferior vena cava; LAVI, left atrial volume index; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; LVOT-VTI, left ventricular outflow tract-velocity time integral; MR, mitral regurgitation; RVFAC, right ventricular fractional area change; TAPSE, tricuspid annular plane systolic excursion; T-Bil, total bilirubin; TR, tricuspid regurgitation; TRPG, tricuspid regurgitation peak gradient.